COMP <GO>
GRDN vs PEP // RSI-14 & 200D SMA MOMENTUM
Guardian Pharmacy Services Inc. (Class A) (NYSE) VS. PepsiCo Inc. (NASDAQ) • 15-METRIC TALLY: GRDN 4
— PEP 9
▲ RSI-14 & 200D SMA MOMENTUM LEADER: PEP
LAST: $40.69 (+0.59%) • MKT CAP: $2.56B
rsi-technicals
49.3
LAST: $137.34 (+2.65%) • MKT CAP: $182.32B
rsi-technicals
52.4
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRDN VS. PEP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GRDN | PEP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.20% | 54.10% | -33.90 | PEP | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 37.70% | 17.00% | +20.70 | GRDN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.3x | 14.3x | +20.00 | PEP | /valuation <GO> |
| Free Cash Flow Yield | 3.91% | 4.31% | -0.40 | PEP | /fcf-yield <GO> |
| Operating Margin | 5.00% | 12.20% | -7.20 | PEP | /operating-margins <GO> |
| Net Profit Margin | 3.40% | 8.80% | -5.40 | PEP | /net-margins <GO> |
| Revenue Growth (YoY) | 17.90% | 2.30% | +15.60 | GRDN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 4.19% | -4.19 | PEP | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.39 | 3.38 | +9.01 | GRDN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | GRDN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 49.3 | 52.4 | -3.10 | PEP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.89 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 43.8x | 20.6x | +23.20 | PEP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.56B | $182.32B | -$179.76B | PEP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GRDN REV | PEP REV | GRDN GROSS % | PEP GROSS % | GRDN FCF | PEP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.45B | $93.92B | 20.2% | 54.1% | $100.3M | $7.86B |
| FY 2024 | $1.23B | $91.85B | 19.9% | 54.6% | $58.0M | $8.37B |
| FY 2023 | — | $91.47B | — | — | — | $9.33B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRDN // BETA —
PEP // BETA 0.89